These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34629821)

  • 1. Exosomal microRNA-588 from M2 polarized macrophages contributes to cisplatin resistance of gastric cancer cells.
    Cui HY; Rong JS; Chen J; Guo J; Zhu JQ; Ruan M; Zuo RR; Zhang SS; Qi JM; Zhang BH
    World J Gastroenterol; 2021 Sep; 27(36):6079-6092. PubMed ID: 34629821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells.
    Zheng P; Chen L; Yuan X; Luo Q; Liu Y; Xie G; Ma Y; Shen L
    J Exp Clin Cancer Res; 2017 Apr; 36(1):53. PubMed ID: 28407783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosome-Derived Circ-PVT1 Contributes to Cisplatin Resistance by Regulating Autophagy, Invasion, and Apoptosis Via miR-30a-5p/YAP1 Axis in Gastric Cancer Cells.
    Yao W; Guo P; Mu Q; Wang Y
    Cancer Biother Radiopharm; 2021 May; 36(4):347-359. PubMed ID: 32799541
    [No Abstract]   [Full Text] [Related]  

  • 4. Circular RNA circVAPA promotes chemotherapy drug resistance in gastric cancer progression by regulating miR-125b-5p/STAT3 axis.
    Deng P; Sun M; Zhao WY; Hou B; Li K; Zhang T; Gu F
    World J Gastroenterol; 2021 Feb; 27(6):487-500. PubMed ID: 33642823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.
    Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H
    Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linc00852 from cisplatin-resistant gastric cancer cell-derived exosomes regulates COMMD7 to promote cisplatin resistance of recipient cells through microRNA-514a-5p.
    Cao S; Fu B; Cai J; Zhang D; Wang C; Wu H
    Cell Biol Toxicol; 2023 Apr; 39(2):483-496. PubMed ID: 35088190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophages enhance cisplatin resistance in gastric cancer through the transfer of circTEX2.
    Qu B; Liu J; Peng Z; Xiao Z; Li S; Wu J; Li S; Luo J
    J Cell Mol Med; 2024 Mar; 28(5):e18070. PubMed ID: 38102848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-206 facilitates gastric cancer cell apoptosis and suppresses cisplatin resistance by targeting MAPK2 signaling pathway.
    Chen Z; Gao YJ; Hou RZ; Ding DY; Song DF; Wang DY; Feng Y
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):171-180. PubMed ID: 30657558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-187 influences cisplatin-resistance of gastric cancer cells through regulating the TGF-β/Smad signaling pathway.
    Zhu QL; Li Z; Lv CM; Wang W
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9907-9914. PubMed ID: 31799659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-200c regulates cisplatin resistance by targeting ZEB2 in human gastric cancer cells.
    Jiang T; Dong P; Li L; Ma X; Xu P; Zhu H; Wang Y; Yang B; Liu K; Liu J; Xue J; Lv R; Su P; Kong G; Chang Y; Zhao C; Wang L
    Oncol Rep; 2017 Jul; 38(1):151-158. PubMed ID: 28534959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal MiR-500a-3p promotes cisplatin resistance and stemness via negatively regulating FBXW7 in gastric cancer.
    Lin H; Zhang L; Zhang C; Liu P
    J Cell Mol Med; 2020 Aug; 24(16):8930-8941. PubMed ID: 32588541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
    Qin X; Yu S; Zhou L; Shi M; Hu Y; Xu X; Shen B; Liu S; Yan D; Feng J
    Int J Nanomedicine; 2017; 12():3721-3733. PubMed ID: 28553110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DDP-resistant ovarian cancer cells-derived exosomal microRNA-30a-5p reduces the resistance of ovarian cancer cells to DDP.
    Liu R; Zhang Y; Sun P; Wang C
    Open Biol; 2020 Apr; 10(4):190173. PubMed ID: 32343928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Let-7b attenuates cisplatin resistance and tumor growth in gastric cancer by targeting AURKB.
    Han X; Zhang JJ; Han ZQ; Zhang HB; Wang ZA
    Cancer Gene Ther; 2018 Dec; 25(11-12):300-308. PubMed ID: 30237418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-1271 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR, and BCL2.
    Yang M; Shan X; Zhou X; Qiu T; Zhu W; Ding Y; Shu Y; Liu P
    Anticancer Agents Med Chem; 2014; 14(6):884-91. PubMed ID: 24875127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal microRNA-107 reverses chemotherapeutic drug resistance of gastric cancer cells through HMGA2/mTOR/P-gp pathway.
    Jiang L; Zhang Y; Guo L; Liu C; Wang P; Ren W
    BMC Cancer; 2021 Dec; 21(1):1290. PubMed ID: 34856955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of CASC2 contributes to cisplatin resistance in gastric cancer by sponging miR-19a.
    Li Y; Lv S; Ning H; Li K; Zhou X; Xv H; Wen H
    Biomed Pharmacother; 2018 Dec; 108():1775-1782. PubMed ID: 30372881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-149 reverses cisplatin resistance of gastric cancer SGC7901/DDP cells by targeting FoxM1.
    Li X; Liang J; Liu YX; Wang Y; Yang XH; Luan BH; Zhang GL; Du J; Wu XH
    Pharmazie; 2016 Nov; 71(11):640-643. PubMed ID: 29441968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosome-delivered circRNA circSYT15 contributes to cisplatin resistance in cervical cancer cells through the miR-503-5p/RSF1 axis.
    Chen Z; Xu Z; Wang Q; Wang L; Zhang H; Wang W; Zhao H; Guo Y; Cui J
    Cell Cycle; 2023 Oct; 22(20):2211-2228. PubMed ID: 37974391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-20a induces cisplatin resistance of a human gastric cancer cell line via targeting CYLD.
    Zhu M; Zhou X; Du Y; Huang Z; Zhu J; Xu J; Cheng G; Shu Y; Liu P; Zhu W; Wang T
    Mol Med Rep; 2016 Aug; 14(2):1742-50. PubMed ID: 27357419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.